BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 36224758)

  • 1. Genome editing technologies, mechanisms and improved production of therapeutic phytochemicals: Opportunities and prospects.
    Mitra S; Anand U; Ghorai M; Kant N; Kumar M; Radha ; Jha NK; Swamy MK; Proćków J; de la Lastra JMP; Dey A
    Biotechnol Bioeng; 2023 Jan; 120(1):82-94. PubMed ID: 36224758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR/Cas genome editing to optimize pharmacologically active plant natural products.
    Dey A
    Pharmacol Res; 2021 Feb; 164():105359. PubMed ID: 33285226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR-based metabolic editing: Next-generation metabolic engineering in plants.
    Sabzehzari M; Zeinali M; Naghavi MR
    Gene; 2020 Oct; 759():144993. PubMed ID: 32717311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR/Cas9-Based Genome Editing in Plants.
    Zhang Y; Ma X; Xie X; Liu YG
    Prog Mol Biol Transl Sci; 2017; 149():133-150. PubMed ID: 28712494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome editing in plants: Advancing crop transformation and overview of tools.
    Shah T; Andleeb T; Lateef S; Noor MA
    Plant Physiol Biochem; 2018 Oct; 131():12-21. PubMed ID: 29754773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR/Cas9: an advanced tool for editing plant genomes.
    Samanta MK; Dey A; Gayen S
    Transgenic Res; 2016 Oct; 25(5):561-73. PubMed ID: 27012546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPER/Cas in Plant Natural Product Research: Therapeutics as Anticancer and other Drug Candidates and Recent Patents.
    Dey A; Nandy S
    Recent Pat Anticancer Drug Discov; 2021; 16(4):460-468. PubMed ID: 34911411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The era of editing plant genomes using CRISPR/Cas: A critical appraisal.
    Bhat MA; Bhat MA; Kumar V; Wani IA; Bashir H; Shah AA; Rahman S; Jan AT
    J Biotechnol; 2020 Dec; 324():34-60. PubMed ID: 32980369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can genetic engineering-based methods for gene function identification be eclipsed by genome editing in plants? A comparison of methodologies.
    Amritha PP; Shah JM
    Mol Genet Genomics; 2021 May; 296(3):485-500. PubMed ID: 33751237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in Plant Epigenome Editing Research and Its Application in Plants.
    Qi Q; Hu B; Jiang W; Wang Y; Yan J; Ma F; Guan Q; Xu J
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Versatile and multifaceted CRISPR/Cas gene editing tool for plant research.
    Pandey PK; Quilichini TD; Vaid N; Gao P; Xiang D; Datla R
    Semin Cell Dev Biol; 2019 Dec; 96():107-114. PubMed ID: 31022459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR-Cas systems: Challenges and future prospects.
    Gohil N; Bhattacharjee G; Lam NL; Perli SD; Singh V
    Prog Mol Biol Transl Sci; 2021; 180():141-151. PubMed ID: 33934835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unraveling the promise and limitations of CRISPR/Cas system in natural product research: Approaches and challenges.
    Biswas P; Anand U; Ghorai M; Pandey DK; Jha NK; Behl T; Kumar M; Chauhan R; Shekhawat MS; Dey A
    Biotechnol J; 2022 Jul; 17(7):e2100507. PubMed ID: 34882991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR-Cas9 system: A new-fangled dawn in gene editing.
    Gupta D; Bhattacharjee O; Mandal D; Sen MK; Dey D; Dasgupta A; Kazi TA; Gupta R; Sinharoy S; Acharya K; Chattopadhyay D; Ravichandiran V; Roy S; Ghosh D
    Life Sci; 2019 Sep; 232():116636. PubMed ID: 31295471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [CRISPR/Cas9 technology in disease research and therapy: a review].
    Shi M; Shen Z; Zhang N; Wang L; Yu C; Yang Z
    Sheng Wu Gong Cheng Xue Bao; 2021 Apr; 37(4):1205-1228. PubMed ID: 33973436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Application of CRISPR-Cas9 gene editing technology in crop breeding].
    Yin W; Chen Z; Huang J; Ye H; Lu T; Lu M; Rao Y
    Sheng Wu Gong Cheng Xue Bao; 2023 Feb; 39(2):399-424. PubMed ID: 36847080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential Application of CRISPR/Cas9 System to Engineer Abiotic Stress Tolerance in Plants.
    Ahmed T; Noman M; Shahid M; Muhammad S; Tahir Ul Qamar M; Ali MA; Maqsood A; Hafeez R; Ogunyemi SO; Li B
    Protein Pept Lett; 2021; 28(8):861-877. PubMed ID: 33602066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concerns regarding 'off-target' activity of genome editing endonucleases.
    Kadam US; Shelake RM; Chavhan RL; Suprasanna P
    Plant Physiol Biochem; 2018 Oct; 131():22-30. PubMed ID: 29653762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [CRISPR/Cas9-based genome editing systems and the analysis of targeted genome mutations in plants].
    Ma XL; Liu YG
    Yi Chuan; 2016 Feb; 38(2):118-25. PubMed ID: 26907775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manipulating the Biosynthesis of Bioactive Compound Alkaloids for Next-Generation Metabolic Engineering in Opium Poppy Using CRISPR-Cas 9 Genome Editing Technology.
    Alagoz Y; Gurkok T; Zhang B; Unver T
    Sci Rep; 2016 Aug; 6():30910. PubMed ID: 27483984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.